Therapeutic areas

EastHORN has been engaged in Phase I to Phase IV studies, covering every major therapeutic area: oncology, cardiology, ophthalmology, neurology and psychiatry, infectious diseases, gastroenterology, urology and nephrology, dermatology, immunology, metabolic disorders, pediatrics, medical devices as well as a wide range of rare diseases.

EastHORN staff includes experienced physicians with extensive medical expertise across multiple therapeutic areas. Our experts can utilise their knowledge to review your protocol, identify patient populations, potential challenges and provide specific guidance on your drug development program.